Chronic inflammation in the kidneys and vascular wall is a major contributor to hypertension.
However, the stimuli and cellular mechanisms responsible for such inflammatory responses …

The vascular endothelium is a dynamic endocrine organ that regulates contractile, secretory,
and mitogenic activities in the vessel wall and hemostatic processes within the vascular …

Objectives: We sought to investigate the effects of intensive cholesterol reduction on large
artery stiffness and blood pressure in normolipidemic patients with isolated systolic …

The 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase inhibitors, more
commonly known as statins, are a class of drug widely used for the treatment of …

The burden of cardiovascular disease (CVD) is increasing worldwide. The increase in the
burden is a major concern in developing countries like India. It is well-established that …

Background By the lengthening of life span, the incidence of chronic diseases such as
hypertension and uncontrolled hypertension has increased. This study aims to determine …

Background—Decreased heart rate variability (HRV) and increased blood pressure
variability (BPV), determined in part by nitric oxide (NO)–dependent endothelial dysfunction …

Inhibitors of HMG-CoA reductase (statins) are potent cholesterol-lowering drugs. Large
clinical trials have shown that statins reduce the incidence of cerebrovascular events, which …

Background Some studies have suggested reductions in blood pressure (BP) with statin
treatment, particularly in persons with hypertension. Randomized trial evidence is limited …

Hypertension, a prevalent risk factor for cardiovascular disease, frequently occurs in
conjunction with metabolic disturbances and in particular with dyslipidaemia; such …